Response to “Comment on E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism”

Giuseppe Lippi; Gianfranco Cervellin; Emmanuel J. Favaloro

doi:10.1055/s-0034-1375703

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2014; 40(04): 519-520
DOI: 10.1055/s-0034-1375703

Letter to the Editor

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Response to “Comment on E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism”

Authors

Giuseppe Lippi

¹Laboratory of Clinical Chemistry and Hematology, Academic Hospital of Parma, Parma, Italy
Gianfranco Cervellin

²Emergency Department, Academic Hospital of Parma, Parma, Italy
Emmanuel J. Favaloro

³Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, New South Wales, Australia

Abstract

Full Text

References

References
1 Lippi G, Favaloro EJ, Meschi T, Mattiuzzi C, Borghi L, Cervellin G. E-cigarettes and cardiovascular risk: beyond science and mysticism. Semin Thromb Hemost 2014; 40: 60-65
2 Farsalinos KE, Romagna G, Le Houezec J. Comment on E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism . Semin Thromb Hemost 2014; 40 (4) 517-518
3 Waldum HL, Nilsen OG, Nilsen T , et al. Long-term effects of inhaled nicotine. Life Sci 1996; 58 (16) 1339-1346
4 Greenland S, Satterfield MH, Lanes SF. A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf 1998; 18 (4) 297-308
5 Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ 2009; 339: b3060
6 Ottervanger JP, Festen JM, de Vries AG, Stricker BH. Acute myocardial infarction while using the nicotine patch. Chest 1995; 107: 1765-1766
7 Arnaot MR. Treating heart disease. Nicotine patches may not be safe. BMJ 1995; 310: 663-664
8 Ottervanger JP, Wilson JH, Stricker BH. Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature. Eur J Clin Pharmacol 1997; 53: 105-110
9 Lee AH, Afessa B. The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med 2007; 35: 1517-1521
10 Santanam N, Thornhill BA, Lau JK , et al. Nicotinic acetylcholine receptor signaling in atherogenesis. Atherosclerosis 2012; 225: 264-273
11 O'Brien SH. Contraception-related venous thromboembolism in adolescents. Semin Thromb Hemost 2014; 40: 66-71
12 Hsu R, Myers AE, Ribisl KM, Marteau TM. An observational study of retail availability and in-store marketing of e-cigarettes in London: potential to undermine recent tobacco control gains?. BMJ Open 2013; 3: e004085
13 Solarino B, Rosenbaum F, Riesselmann B, Buschmann CT, Tsokos M. Death due to ingestion of nicotine-containing solution: case report and review of the literature. Forensic Sci Int 2010; 195: e19-e22
14 Cervellin G, Luci M, Bellini C, Lippi G. Bad news about an old poison. A case of nicotine poisoning due to both ingestion and injection of the content of an electronic cigarette refill. Emerg Care J 2013; 9 (2) e18
15 Chen IL. FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res 2013; 15: 615-616
16 Cantrell FL. Adverse effects of e-cigarette exposures. J Community Health 2013; ; doi: 10.1007/s10900-013-9807-5
17 Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control 2014; 23: 77-78
18 Connolly GN, Richter P, Aleguas Jr A, Pechacek TF, Stanfill SB, Alpert HR. Unintentional child poisonings through ingestion of conventional and novel tobacco products. Pediatrics 2010; 125: 896-899